These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 11059633

  • 1. Efficacy and tolerability of candesartan cilexetil in special patient groups.
    Trenkwalder P.
    Blood Press Suppl; 2000; 1():27-30. PubMed ID: 11059633
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and Tolerability of Candesartan Cilexetil in Special Patient Groups.
    Trenkwalder P.
    Blood Press; 2000; 9(sup1):27-30. PubMed ID: 28425801
    [Abstract] [Full Text] [Related]

  • 3. Preserving target-organ function with candesartan cilexetil in patients with hypertension.
    Zannad F.
    Blood Press Suppl; 2000; 1():36-9. PubMed ID: 11059635
    [Abstract] [Full Text] [Related]

  • 4. Improving antihypertensive efficacy while maintaining placebo-like tolerability.
    Sever PS.
    Blood Press Suppl; 2000; 1():19-22. PubMed ID: 11059631
    [Abstract] [Full Text] [Related]

  • 5. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
    Baumgart P, Reismann J, Pohlmeyer H, Düsing R.
    Dtsch Med Wochenschr; 2001 May 11; 126(19):547-50. PubMed ID: 11402910
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population.
    McInnes GT, O'Kane KP, Jonker J, Roth J.
    J Hum Hypertens; 1997 Sep 11; 11 Suppl 2():S75-80. PubMed ID: 9331015
    [Abstract] [Full Text] [Related]

  • 8. Reducing cardiovascular morbidity and mortality in the elderly.
    Trenkwalder P.
    Blood Press Suppl; 2000 Sep 11; 1():40-3. PubMed ID: 11059636
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Achieving quality 24-h blood pressure control with candesartan cilexetil.
    Meredith P.
    Blood Press Suppl; 2000 Sep 11; 1():23-6. PubMed ID: 11059632
    [Abstract] [Full Text] [Related]

  • 12. Candesartan cilexetil: safety and tolerability in healthy volunteers and patients with hypertension.
    Belcher G, Hübner R, George M, Elmfeldt D, Lunde H.
    J Hum Hypertens; 1997 Sep 11; 11 Suppl 2():S85-9. PubMed ID: 9331017
    [Abstract] [Full Text] [Related]

  • 13. Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil.
    Sever PS.
    J Hypertens Suppl; 1997 Dec 11; 15(6):S9-12. PubMed ID: 9493121
    [Abstract] [Full Text] [Related]

  • 14. Switch from ABCD pretreatment to A-II-A treatment: a multinational, open, centrally randomized, prospective parallel group comparison.
    Asmar R, Porcellati C, Dusing R.
    Drugs Exp Clin Res; 2004 Dec 11; 30(4):153-61. PubMed ID: 15553661
    [Abstract] [Full Text] [Related]

  • 15. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
    Baguet JP, Nisse-Durgeat S, Mouret S, Asmar R, Mallion JM.
    Int J Clin Pract; 2006 Apr 11; 60(4):391-8. PubMed ID: 16620350
    [Abstract] [Full Text] [Related]

  • 16. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension.
    Sever P, Holzgreve H.
    J Hum Hypertens; 1997 Sep 11; 11 Suppl 2():S69-73. PubMed ID: 9331014
    [Abstract] [Full Text] [Related]

  • 17. Candesartan in the treatment of hypertension: what have we learnt in the last decade?
    Barrios V, Escobar C.
    Expert Opin Drug Saf; 2011 Nov 11; 10(6):957-68. PubMed ID: 21848481
    [Abstract] [Full Text] [Related]

  • 18. Candesartan cilexetil: in children and adolescents aged 1 to <17 years with hypertension.
    Hoy SM, Keating GM.
    Am J Cardiovasc Drugs; 2010 Nov 11; 10(5):335-42. PubMed ID: 20860416
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.